ArticleNeurology. Genetics2021
Open access · goldAbstract read
In one paragraph
Article in Neurology. Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 27% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.
- Pooled it
- Disruption of DNA Repair as an Emerging Epigenetic Mechanism Underlying Autism Spectrum Disorder.Current psychiatry reports · 2026Review
- Neurodevelopmental origins of age-related neurodegenerative diseases.EBioMedicine · 2026Review
- Genetics and Phenotypes of Late-Onset Neurodegeneration in Neurodevelopmental Disorders.Cureus · 2025Review
- A spatial single-cell atlas of the claustro-insular region uncovers key regulators of neuronal identity and excitability.Nature communications · 2025Article
- Purine Metabolism and Dystonia: Perspectives of a Long-Promised Relationship.Annals of neurology · 2025Review
- Large-scale transcriptomic analyses of major depressive disorder reveal convergent dysregulation of synaptic pathways in excitatory neurons.Nature communications · 2025Article
- Combined molecular characterization and dopa-responsive treatment in two patients with NR4A2-associated intellectual developmental disorder.Frontiers in genetics · 2025Article
- Next-generation sequencing and bioinformatics in rare movement disorders.Nature reviews. Neurology · 2024Review
- Mutations, Genes, and Phenotypes Related to Movement Disorders and Ataxias.International journal of molecular sciences · 2022Article
- Two novel heterozygous truncating variants inFrontiers in neuroscience · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 1 institution in 1 country.
Silvia JesúsUnidad de Trastornos del Movimiento (S.J., F.C., D.M.-G., A.A., P.M.), Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED) (S.J., F.C., D.M.-G., A.A., P.M.), Spain; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Joint Units INCLIVA and IIS La Fe Rare Diseases (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Department of Pediatric Neurology (B.P.-D.), Hospital Universitari Vall d'Hebron, Barcelona, Spain; and Universitat Autònoma de Barcelona (B.P.-D.), Spain.
Isabel HinarejosUnidad de Trastornos del Movimiento (S.J., F.C., D.M.-G., A.A., P.M.), Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED) (S.J., F.C., D.M.-G., A.A., P.M.), Spain; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Joint Units INCLIVA and IIS La Fe Rare Diseases (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Department of Pediatric Neurology (B.P.-D.), Hospital Universitari Vall d'Hebron, Barcelona, Spain; and Universitat Autònoma de Barcelona (B.P.-D.), Spain.ORCID 0000-0001-9548-4359
Fátima CarrilloUnidad de Trastornos del Movimiento (S.J., F.C., D.M.-G., A.A., P.M.), Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED) (S.J., F.C., D.M.-G., A.A., P.M.), Spain; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Joint Units INCLIVA and IIS La Fe Rare Diseases (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Department of Pediatric Neurology (B.P.-D.), Hospital Universitari Vall d'Hebron, Barcelona, Spain; and Universitat Autònoma de Barcelona (B.P.-D.), Spain.
Dolores Martínez-RubioUnidad de Trastornos del Movimiento (S.J., F.C., D.M.-G., A.A., P.M.), Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED) (S.J., F.C., D.M.-G., A.A., P.M.), Spain; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Joint Units INCLIVA and IIS La Fe Rare Diseases (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Department of Pediatric Neurology (B.P.-D.), Hospital Universitari Vall d'Hebron, Barcelona, Spain; and Universitat Autònoma de Barcelona (B.P.-D.), Spain.
Daniel Macías-GarcíaUnidad de Trastornos del Movimiento (S.J., F.C., D.M.-G., A.A., P.M.), Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED) (S.J., F.C., D.M.-G., A.A., P.M.), Spain; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Joint Units INCLIVA and IIS La Fe Rare Diseases (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Department of Pediatric Neurology (B.P.-D.), Hospital Universitari Vall d'Hebron, Barcelona, Spain; and Universitat Autònoma de Barcelona (B.P.-D.), Spain.
Ana Sánchez-MonteagudoUnidad de Trastornos del Movimiento (S.J., F.C., D.M.-G., A.A., P.M.), Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED) (S.J., F.C., D.M.-G., A.A., P.M.), Spain; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Joint Units INCLIVA and IIS La Fe Rare Diseases (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Department of Pediatric Neurology (B.P.-D.), Hospital Universitari Vall d'Hebron, Barcelona, Spain; and Universitat Autònoma de Barcelona (B.P.-D.), Spain.
Astrid AdarmesUnidad de Trastornos del Movimiento (S.J., F.C., D.M.-G., A.A., P.M.), Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED) (S.J., F.C., D.M.-G., A.A., P.M.), Spain; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Joint Units INCLIVA and IIS La Fe Rare Diseases (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Department of Pediatric Neurology (B.P.-D.), Hospital Universitari Vall d'Hebron, Barcelona, Spain; and Universitat Autònoma de Barcelona (B.P.-D.), Spain.
Vincenzo LupoUnidad de Trastornos del Movimiento (S.J., F.C., D.M.-G., A.A., P.M.), Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED) (S.J., F.C., D.M.-G., A.A., P.M.), Spain; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Joint Units INCLIVA and IIS La Fe Rare Diseases (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Department of Pediatric Neurology (B.P.-D.), Hospital Universitari Vall d'Hebron, Barcelona, Spain; and Universitat Autònoma de Barcelona (B.P.-D.), Spain.
Belén Pérez-DueñasUnidad de Trastornos del Movimiento (S.J., F.C., D.M.-G., A.A., P.M.), Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED) (S.J., F.C., D.M.-G., A.A., P.M.), Spain; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Joint Units INCLIVA and IIS La Fe Rare Diseases (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Department of Pediatric Neurology (B.P.-D.), Hospital Universitari Vall d'Hebron, Barcelona, Spain; and Universitat Autònoma de Barcelona (B.P.-D.), Spain.
Pablo MirUnidad de Trastornos del Movimiento (S.J., F.C., D.M.-G., A.A., P.M.), Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED) (S.J., F.C., D.M.-G., A.A., P.M.), Spain; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Joint Units INCLIVA and IIS La Fe Rare Diseases (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Department of Pediatric Neurology (B.P.-D.), Hospital Universitari Vall d'Hebron, Barcelona, Spain; and Universitat Autònoma de Barcelona (B.P.-D.), Spain.ORCID 0000-0003-1656-302X
Carmen EspinósUnidad de Trastornos del Movimiento (S.J., F.C., D.M.-G., A.A., P.M.), Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED) (S.J., F.C., D.M.-G., A.A., P.M.), Spain; Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Joint Units INCLIVA and IIS La Fe Rare Diseases (I.H., D.M.-R., A.S.-M., V.L., C.E.), Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain; Department of Pediatric Neurology (B.P.-D.), Hospital Universitari Vall d'Hebron, Barcelona, Spain; and Universitat Autònoma de Barcelona (B.P.-D.), Spain.ORCID 0000-0003-4435-1809
Instituto de Biomedicina de Sevilla · ES
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.